Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor α for In-Transit Melanoma and Soft Tissue Sarcoma.
Smith, H G
Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor α for In-Transit Melanoma and Soft Tissue Sarcoma. [electronic resource] - Annals of surgical oncology Dec 2015 - S356-61 p. digital
Publication Type: Journal Article
1534-4681
10.1245/s10434-015-4856-x doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating--administration & dosage
Chemotherapy, Cancer, Regional Perfusion--methods
Cohort Studies
Drug Therapy, Combination
Extremities
Female
Follow-Up Studies
Humans
Limb Salvage
Male
Melanoma--drug therapy
Melphalan--administration & dosage
Middle Aged
Neoplasm Staging
Prognosis
Sarcoma--drug therapy
Survival Rate
Tumor Necrosis Factor-alpha--administration & dosage
Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor α for In-Transit Melanoma and Soft Tissue Sarcoma. [electronic resource] - Annals of surgical oncology Dec 2015 - S356-61 p. digital
Publication Type: Journal Article
1534-4681
10.1245/s10434-015-4856-x doi
Adult
Aged
Aged, 80 and over
Antineoplastic Agents, Alkylating--administration & dosage
Chemotherapy, Cancer, Regional Perfusion--methods
Cohort Studies
Drug Therapy, Combination
Extremities
Female
Follow-Up Studies
Humans
Limb Salvage
Male
Melanoma--drug therapy
Melphalan--administration & dosage
Middle Aged
Neoplasm Staging
Prognosis
Sarcoma--drug therapy
Survival Rate
Tumor Necrosis Factor-alpha--administration & dosage